Valuation: Becton, Dickinson and Company

Market Cap 43.56B 38.06B 34.95B 32.59B 61.79B 4,147B 62.83B 421B 163B 2,034B 164B 160B 7,008B P/E 2026 *
39.4x
P/E 2027 * 30.4x
Enterprise Value 59.51B 52B 47.75B 44.53B 84.42B 5,666B 85.85B 575B 223B 2,779B 223B 219B 9,575B EV / Sales 2026 *
3.1x
EV / Sales 2027 * 2.92x
Free-Float
74.04%
Yield 2026 *
2.44%
Yield 2027 * 2.48%
1 day+3.39%
1 week+4.43%
Current month+4.46%
1 month+9.45%
3 months+2.31%
6 months-18.91%
Current year-18.54%
1 week 149.69
Extreme 149.69
158.72
1 month 140.11
Extreme 140.11
158.72
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+3.39%+4.43%-10.83%-40.12% 43.56B
+3.49%+2.32%-28.86%-12.49% 166B
+5.04%+3.32%-5.77%-5.57% 106B
+2.80%+3.33%+1.83%+54.09% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.2B
+3.50%+14.35% - - 36.52B
+3.47%+3.79%-14.75%-44.56% 27.49B
+0.20%+5.53%+65.33%-4.37% 25.84B
+2.78%+3.61%-8.42%-3.01% 21.27B
+2.19%+2.88%-11.21%-20.38% 20.28B
Average +2.82%+4.02%+4.50%-2.95% 55.85B
Weighted average by Cap. +3.27%+3.28%-3.97%-0.88%

Financials

2026 *2027 *
Net sales 19.21B 16.78B 15.41B 14.37B 27.24B 1,828B 27.7B 186B 71.91B 897B 72.11B 70.54B 3,090B 19.71B 17.22B 15.82B 14.75B 27.96B 1,876B 28.43B 190B 73.8B 920B 74.01B 72.4B 3,171B
Net income 1.12B 983M 902M 842M 1.6B 107B 1.62B 10.87B 4.21B 52.51B 4.22B 4.13B 181B 1.45B 1.27B 1.16B 1.08B 2.06B 138B 2.09B 14B 5.43B 67.67B 5.44B 5.32B 233B
Net Debt 15.95B 13.94B 12.8B 11.94B 22.63B 1,519B 23.01B 154B 59.74B 745B 59.91B 58.61B 2,567B 14.07B 12.3B 11.29B 10.53B 19.96B 1,340B 20.3B 136B 52.69B 657B 52.84B 51.69B 2,264B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
02/07/26 USD 158.08 +3.39% 2,040,521
01/07/26 USD 152.90 +1.04% 2,131,647
30/06/26 USD 151.33 -2.49% 2,109,075
29/06/26 USD 155.19 -0.47% 2,396,596
26/06/26 USD 155.92 +3.00% 12,180,748
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
158.08USD
Average target price
177.75USD
Spread / Average Target
+12.44%

Quarterly revenue - Rate of surprise